Nutritional Assessment Intervention to Improve Cancer-Related Fatigue
|ClinicalTrials.gov Identifier: NCT00507260|
Recruitment Status : Completed
First Posted : July 26, 2007
Last Update Posted : December 24, 2014
1. To use the results from this pilot study to estimate the effect size of the nutritional intervention on fatigue and caloric intake.
- To apply nutritional assessment tools for early detection of patients at risk for malnutrition.
- To examine the feasibility of conducting this intervention study.
- To describe cancer-related fatigue patterns among BMT patients at multiple time points during ambulatory visits.
- To evaluate the effects of a nutritional intervention for post-allogeneic BMT recipients on adequacy of caloric intake in order to improve cancer-related fatigue scores.
|Condition or disease||Intervention/treatment||Phase|
|Leukemia Lymphoma Fatigue||Behavioral: Food Record Other: Nutritional Consults||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pilot Study to Evaluate a Nutritional Assessment Intervention to Improve Cancer-Related Fatigue Among Post-Allogeneic Blood and Marrow Transplantation Recipients|
|Study Start Date :||September 2006|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Experimental: Control Group
Control Group (Food Record)
Behavioral: Food Record
A record of the amount and kind of food and drink you intake will be completed.
Experimental: Treatment Group
Treatment Group (Food Record + Nutritional Consults)
Behavioral: Food Record
A record of the amount and kind of food and drink you intake will be completed.Other: Nutritional Consults
Meeting with a dietician consultant regarding issues related to food intake. Participants will also receive the results from the food records.
- Patient Fatigue Scores <Brief Fatigue Inventory (BFI)> [ Time Frame: BFI at study day 0, 14, 28, and 42 ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00507260
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Srisuda Lecagoonporn, RN||M.D. Anderson Cancer Center|